PURPOSE: Investigate efficacy and safety of @entity4530 revision using @entity1138 after Ex-PRESS shunt surgery. @entity1 AND METHODS: We performed chart reviews of 36 consecutive eyes from 34 @entity1 with previous Ex-PRESS shunt surgery who underwent subsequent @entity4530 revision with @entity1138 . The mean follow-up time was 13.5 months. The primary outcome measure was surgical success. Secondary outcomes included visual acuity, intraocular pressure, number of medications, and complications. RESULTS: Twenty-four eyes had @entity1538 (61.1%). Mean time from Ex-PRESS to @entity4530 revision was 8.8 months. Complete success rate for the immediate 3-month postoperative period was 94.4% and qualified success rate was 97.2%. Complete and qualified success rates for the entire follow-up period were 40% and 65.7%, respectively. Visual acuity remained stable throughout the study period, and at 1 year, average intraocular pressure was 14.7 mm Hg on an average of 1.7 medications. No major complications were reported. CONCLUSIONS: Bleb revision in eyes with an Ex-PRESS shunt is a safe and efficacious procedure. The surgical outcomes are within the range of published outcomes for @entity4530 needling after trabeculectomy. Further research with larger sample size and longer follow-up is needed to confirm these results.

Outcomes of Bleb Revision With XXXX After Ex-PRESS Shunt Surgery.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity1138 :: ('MESH:D016685', 'Chemical') :: ['mitomycin C'] @entity1538 :: ('MESH:D005902', 'Disease') :: ['open-angle glaucoma'] @entity4530 :: ('MESH:D001768', 'Disease') :: ['bleb']
@entity1138 :: (MESH:D016685,Chemical) :: ['Mitomycin C']
